Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Chemical Biology

Stephen Caddick's Biography



Stephen Caddick, Vice Provost for Enterprise, University College London

Professor Caddick was appointed as Vice-Provost (Enterprise) in 2010, and is responsible for leading UCL's enterprise agenda including: knowledge transfer and exchange, business relationships and partnerships, entrepreneurship, innovation and social enterprise. He joined UCL in 2003 as Vernon Professor of Organic Chemistry and Chemical Biology. He was the founding director of the UCL Centre for Chemical Biology, and, from 2008-2010 served as Head of the Department of Chemistry. Professor Caddick has a major research group in Organic Synthesis and Chemical Biology with a particular focus on the development of novel and sustainable synthetic methods for applications in biological and biomedical research. He has served on a number of EPSRC, BBSRC and MRC funding panels and committees and is currently a member of MRCT's Drug Discovery Advisory Board. He has played key role in developing the unique contribution UCL will make to the Francis Crick Institute (formerly UKCMRI), which will bring the university together with Cancer Research UK, the Medical Research Council and the Wellcome Trust in a new institute in central London to undertake cutting-edge research and training of medical scientists to advance our understanding of health and disease. He is Chairman of the Bloomsbury Bioseed Fund and a Non-Executive director of UCL Business. He was founder of the open access publishing website SyntheticPages and a founder of biotech spin-out Thiologics. Professor Caddick served on the Review Panel of the Wilson Review of Business-University Collaboration, released in early 2012.

Stephen Caddick Image

Chemical Modification of Proteins

Tuesday, 19 March 2013 at 16:00

Add to Calendar ▼2013-03-19 16:00:002013-03-19 17:00:00Europe/LondonChemical Modification of Proteins SELECTBIOenquiries@selectbiosciences.com

The ability to prepare chemical modified proteins is essential for fundamental chemical biology and the development of protein therapeutics. This presentation will provide an overview of recent studies directed toward developing novel chemical methods for the selective covalent modification of a variety of proteins. A discussion of broad ranging application in chemical biology and therapeutic innovation will be presented.


Add to Calendar ▼2013-03-19 00:00:002013-03-20 00:00:00Europe/LondonChemical BiologySELECTBIOenquiries@selectbiosciences.com